Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial (Q42098491)
Jump to navigation
Jump to search
scientific article published on 12 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial |
scientific article published on 12 August 2012 |
Statements
1 reference
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial (English)
1 reference
1 reference
1 reference
Donald K Bowden
1 reference
Marina Economou
1 reference
Jacques Troncy
1 reference
Arnold Ganser
1 reference
Dany Habr
1 reference
Adam Gater
1 reference
Diana Rofail
1 reference
Linda Abetz-Webb
1 reference
Helen Lau
1 reference
12 August 2012
1 reference
1 reference
2012
1 reference
297641
1 reference
1 January 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference